Spontaneous Blink Rates Correlate with Dopamine Levels in the Caudate Nucleus of MPTP-Treated Monkeys

By Taylor J.R.   Elsworth J.D.   Lawrence M.S.   Sladek J.R.   Roth R.H.   Redmond D.E.  

Experimental Neurology, Vol. 158, Iss. 1, 1999-07 ,pp. : 214-220

Elsevier

Access to resources Recommend Favorite

Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey

By Boraud T.   Bezard E.   Bioulac B.   Gross C.E.  

Brain, Vol. 124, Iss. 3, 2001-03 ,pp. : 546-557

Oxford University Press

Access to resources Recommend Favorite

MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations

By Laloux Charlotte   Derambure Philippe   Kreisler Alexandre   Houdayer Elise   Bruezière Servane   Bordet Régis   Destée Alain   Monaca Christelle  

Experimental Brain Research, Vol. 186, Iss. 4, 2008-04 ,pp. : 635-642

Springer Publishing Company

Access to resources Recommend Favorite

Combined Use of the Adenosine A 2A Antagonist KW-6002 with l-DOPA or with Selective D1 or D2 Dopamine Agonists Increases Antiparkinsonian Activity but Not Dyskinesia in MPTP-Treated Monkeys

By Kanda T.   Jackson M.J.   Smith L.A.   Pearce R.K.B.   Nakamura J.   Kase H.   Kuwana Y.   Jenner P.  

Experimental Neurology, Vol. 162, Iss. 2, 2000-04 ,pp. : 321-327

Elsevier

Access to resources Recommend Favorite

Neuroprotective effect of the angiotensin-converting enzyme inhibitor perindopril in MPTP-treated mice

By Kurosaki R.   Muramatsu Y.   Imai Y.   Kato H.   Araki T.  

Neurological Research, Vol. 26, Iss. 6, 2004-09 ,pp. : 644-657

Maney Publishing

Access to resources Recommend Favorite